Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

• Tarun Mehra ,

  Contributed equally to this work with: Tarun Mehra, Judith E. Lupatsch

  Roles Conceptualization, Formal analysis, Investigation, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: tarun.mehra@usz.ch

  Affiliation Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland

  https://orcid.org/0009-0005-8429-5110

  ⨯
• Judith E. Lupatsch ,

  Contributed equally to this work with: Tarun Mehra, Judith E. Lupatsch

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – original draft, Writing – review & editing

  Affiliation Department of Public Health, Institute of Pharmaceutical Medicine (ECPM) and Health Economics Facility, University of Basel, Basel, Switzerland

  ⨯
• Thibaud Kössler,

  Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Service d’oncologie, Hôpitaux Universitaires Genève, Genève, Switzerland

  ⨯
• Konstantin Dedes,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Breast Cancer Center Zürichsee, Zurich, Switzerland

  ⨯
• Alexander Reinhard Siebenhüner,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Onkozentrum Hirslanden Zurich AG and University of Zurich, Zurich, Switzerland

  ⨯
• Roger von Moos,

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Department of Medical Oncology and Hematology, Cantonal Hospital of Graubünden, Chur, Switzerland

  ⨯
• Andreas Wicki ,

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  ¶‡ AW and MES also contributed equally to this work.

  Affiliation Department of Medical Oncology and Hematology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland

  ⨯
• Matthias E. Schwenkglenks

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing

  ¶‡ AW and MES also contributed equally to this work.

  Affiliation Department of Public Health and Head of Research, Health Economics Facility, Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland

  https://orcid.org/0000-0001-7217-1173

  ⨯